Published in J Clin Exp Hepatol on November 23, 2013
A Rare Association of Hepatitis A Virus Infection with Type-1 Diabetes. Clin Pract (2016) 0.75
Hepatocyte Regeneration and Inhibition of Proliferation: Two Sides of a Coin. J Clin Exp Hepatol (2016) 0.75
Clinical features of acute hepatitis E super-infections on chronic hepatitis B. World J Gastroenterol (2016) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Diagnosis and classification of diabetes mellitus. Diabetes Care (2006) 7.91
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med (1998) 5.90
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology (2001) 5.07
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology (2005) 2.18
Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology (1996) 2.18
A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology (2007) 2.07
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care (2007) 1.95
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
The changing scenario of the diabetes epidemic: implications for India. Indian J Med Res (2002) 1.68
Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull World Health Organ (1984) 1.68
Epidemiology of hepatitis B virus infection in India. Gut (1996) 1.64
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58
Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol (2004) 1.44
Diabetes increases the risk of acute hepatic failure. Gastroenterology (2002) 1.39
Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology (2002) 1.38
Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol (2004) 1.31
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol (2004) 1.28
STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol (2002) 1.16
Diabetes mellitus and the risk of primary liver cancer. Int J Cancer (1997) 1.15
Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst (2000) 1.15
Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol (2002) 0.99
Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95
Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci (2001) 0.92
Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Dig Liver Dis (2001) 0.84
Case definition. Acute viral hepatitis. Epidemiol Bull (2002) 0.78
Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol (2014) 1.18
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol (2014) 1.08
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol (2016) 1.02
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol (2014) 0.90
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. J Clin Exp Hepatol (2015) 0.85
Hepatitis e: molecular virology and pathogenesis. J Clin Exp Hepatol (2013) 0.80
Management in acute liver failure. J Clin Exp Hepatol (2014) 0.79
2D Shear Wave Elastography of Liver in Patients with Primary Extrahepatic Portal Vein Obstruction. J Clin Exp Hepatol (2016) 0.75
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]. J Clin Exp Hepatol (2016) 0.75